SCHEMBL7573702

SCHEMBL7573702

CC[C@H](N)c1cccc(C(=O)O)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 3/20 0.73
ENPEP Q07075 2/20 0.73
ALDH1A1 P00352 1/20 0.51
GRM4 Q14833 1/20 0.48
KMT2A Q03164 1/20 0.45
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA9 Q16790 2/20 0.44
CA12 O43570 1/20 0.44
CA6 P23280 1/20 0.44
FOLH1 Q04609 1/20 0.43
NOS3 P29474 1/20 0.43
NOS1 P29475 1/20 0.43
NOS2 P35228 1/20 0.43
MAPT P10636 1/20 0.42
PTGS1 P23219 1/20 0.42
CXCR1 P25024 1/20 0.42
CXCR2 P25025 1/20 0.42
PTGS2 P35354 1/20 0.42
RECQL P46063 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7616448 1.00 ANPEP (0.73) ANPEPENPEPALDH1A1GRM4KMT2A
SCHEMBL7612693 1.00 ANPEP (0.73) ANPEPENPEPALDH1A1GRM4KMT2A
SCHEMBL7615107 0.87 ANPEP (0.69) ANPEPENPEPALDH1A1GRM4KMT2A
SCHEMBL7615099 0.87 ANPEP (0.69) ANPEPENPEPALDH1A1GRM4KMT2A
SCHEMBL7620694 0.87 ANPEP (0.69) ANPEPENPEPALDH1A1GRM4KMT2A
SCHEMBL26547500 0.84 ANPEP (0.75) ANPEPENPEPGRM4CA1CA2
SCHEMBL9843117 0.84 ANPEP (0.59) ANPEPENPEPALDH1A1KMT2ACA1
SCHEMBL321516 0.83 ANPEP (0.73) ANPEPENPEPGRM4KMT2ACA1
SCHEMBL13951835 0.82 ANPEP (0.57) ANPEPENPEPALDH1A1KMT2ACA1
SCHEMBL14231684 0.82 LOXL2 (0.54) ANPEPENPEPALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020183249-A1 Method of identifying inhibitors of CDC25 TAYLOR NEIL R (AU) 2002-12-05 US claimed
WO-2002070680-A1 METHOD OF IDENTIFYING INHIBITORS OF CDC25 BASF AKTIENGESELLSCHAFT (DE) 2002-09-12 WO claimed
US-20020183249-A1 Method of identifying inhibitors of CDC25 TAYLOR NEIL R (AU) 2002-12-05 US disclosed
WO-2001027077-A2 HYDROXYSULFONYLALKYLENE-, PHOSPHONOALKYLENE- OR DIFLUORO(PHOSPHONONON)METHYL- SUBSTITUTED BENZENE, OR BENZOFURAN DERIVATIVES AS NON-PEPTIDIC CDC25 INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 2001-04-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020183249-A1 Method of identifying inhibitors of CDC25 CDC25C, CDC25A, CDC25B ANPEP 521/4885ENPEP 553/4885ALDH1A1 4243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.